Express Pharma

First COVID-19 vaccine human trial finds it is safe, induces immune response

According to the study of 108 adults, the vaccine produced neutralising antibodies, and a response mediated by the immune system's T-cells against the novel coronavirus, SARS-CoV-2

1 20,186